chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tenderness from swollen lymphnodes in arm pit area; Swollen lymph nodes in armpit area; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 22Mar2021 at 10:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included omeprazole (PRILOSEC) OTC as directed on box for an unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 01Mar2021 at 10:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient previously received sulfamethoxazole (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Mar2021, the patient experienced tenderness from swollen lymph nodes in armpit area. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events lymph node tenderness and axillary lymph nodes enlarged. The clinical outcomes of the events lymph node tenderness and axillary lymph nodes enlarged were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Pt had nervousness upon injection which resulted in dizziness, nausea, and vomiting within 5 minutes of injection. Resolved within 20 minutes.
left arm is warm and red to the touch , tender, no itch treatment: doxycycline 100 mg twice daily for 5 days, cool compress for ten minutes three times daily tylenol as needed for pain  follow up on 2/13 if not better
Hives about 2 hours afterwards. More albuterol than normal - throughout the night, weird taste on tongue - soon after injection. Took benedryl to ease itching of hives.
The patient reports feeling achy all over, having arm pain, and having chills that started about 12 hours after vaccine administration. She reported no fever during that time, and did not take any supportive medications to help deal with symptoms. The patient's condition seemed to continue until she spoke with the pharmacy about 24 hours later. The patient was counseled that she could take supportive medication for aches and pains if necessary. The patient was also told to report back to us or her physician if her condition worsened or did not improve.
Lack of energy; Lymph node on shot arm swollen and tender; Fever/fever (98.7); Lymph node on shot arm swollen and tender; Slept for 17 hours; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301308A) via an unspecified route of administration in the right arm on 31Aug2021 at 17:30 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. Medical history included mitral valve prolapse and sleep apnea. The patient had no known allergies.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included flu shot (influenza vaccine) (MANUFACTURER UNKNOWN) on an unknown date of 2021 (reported as the day before) for immunisation; simvastatin (MANUFACTURER UNKNOWN) and clobetasol propionate (CLOP); for unknown indications from unknown dates and unknown if ongoing. On 01Sep2021, first day after shot, the patient experienced a fever, slept for 17 hours and lymph node on shot arm was swollen and tender. On 02Sep2021 (reported as second day), the patient ran fever (98.7 unspecified units). The patient also experienced lack of energy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever/fever (98.7 unspecified units), slept for 17 hours, lymph node on shot arm swollen and tender and lack of energy were resolving at the time of the report.
Initial and follow up information has been received from a physician concerning a 16 year old female who on 12-FEB-2008 (previously reported as 13-FEB-2008) at 4:30 PM was vaccinated IM in the left deltoid with her 1st dose of Gardasil (lot # 658556/1060U). There was no concomitant medication. On 14-FEB-2008 the patient experienced tightness in throat "like something was growing in her throat". The physician instructed the patient to take some BENADRYL. The patient sought unspecified medical attention. Subsequently, the patient recovered from tightness in throat the next day. Additional information has been requested. In follow-up it was reported that the patient experienced throat pain on 12-FEB-2008. Subsequently, on an unspecified date the patient recovered from the throat pain. Initially on 14-FEB-2004 (the next day) it was reported that the patient experienced tightness in throat "like something was growing in her throat" The patient sought medical attention at the doctor's office. It was reported that the patient had received her second dose of GARDASIL (Lot# not reported) without any complication. No additional information is expected.
Pt felt dizzy and pre syncopal post injection of vaccine, patient laid on the floor and was pale but responsive.  BP initially 90/60 but increased to 100/60 after 10 min.  Pt monitored for 30 min and given water but no other medication given.
Joint pain. Headache. Muscle pain. Nausea. Swollen lymph nodes. Fever. Chills. Lethargy.
pt recvd 2nd dose of Hep B on 1DEC91 & 5 mins following vax devel hives; presented to ER & treated w/DPH;
Second dose of Moderna vaccine 4-01-21 at 3:00pm.At 2:30 am high fever 39C walk me up,chills and big headache. 4-03-21 fills little  better but waking up every day with headache. 4-06-21 took half a day off from work because of a big headache. 4-07-21 morning lost speech ability and lost my consciousness. My husband call 911. they are taking me to a hospital I regain my consciousness and speech 2 days later. Diagnosis -Viral brain infection. Stayng in the hospital 7 days still every day with a big headache.
Expired product administered; Vaccine administered after temperature excursion; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.   No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion). On 02-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided
Dizziness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (Dizziness). The patient was treated with VITAMIN C [ASCORBIC ACID] ongoing since an unknown date at a dose of 1 dosage form; VITAMIN D [VITAMIN D NOS] ongoing since an unknown date at a dose of 1 dosage form; VITAMIN B NOS ongoing since an unknown date at a dose of 1 dosage form; UBIDECARENONE (COQ10 [UBIDECARENONE]) ongoing since an unknown date at a dose of 1 dosage form and MAGNESIUM GLYCINATE ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, DIZZINESS (Dizziness) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient stopped drinking diet soda and used glasses that blocks blue light. Concomitant medications were not provided by reporter.    This case was linked to US-MODERNATX, INC.-MOD-2021-232184 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-232184:Other patient who reported events after Moderna vaccine
Fatigue and exhaustion, body aches, chills and diarrhea continuing now for over 2 weeks
Pain experienced at time of injection. Progressive increased pain after one hour. Localized pain with any light shoulder activity during ADL's, raising or leaning on arm, driving, etc. Significant pain with stiffness at night. Requires pain relief medication, experienced loss of work time. Symptoms persist currently.
Patient received Janssen on 03/13/2021 and came back to receive Pfizer on 8/21/2021
Hives and itchiness in the injection site with ~1.5inch radius. This began the day after vaccine although parents were unaware until evening of day 3 when degree of itch prompted complaint. Treatment with topical and oral antihistamine as well as pain medicine for the night.
Fever, headache, extreme fatigue, shortness of breath, lack of appetite for first 10 days.  Fever returned around day 14 or 15 and stayed for another 3 or 4 days. Joint pain, fatigue currently
pt recvd vax JUN94 & 8" area surrounding inj site became red,peeled,hot-to-touch & hard,fever 100;internist,dermatologist & rheumatologist testing nl;sx unrelated to lupus/vasculitis r/o;SEP94 sx resolved;1MAR95 following URTI
Pt was administered Tdap Vaccine on 19NOV13 that expired on 20OCT13. Pt educated vaccine readministered. Pt had no signs or symptoms.
No adverse effects reported; improperly stored doses of PEDVAXHIB (R027325, 7/10/2021) were administered; This spontaneous report as received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On 30-JUN-2019, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot # R027325 has been verified to be a valid lot number, expiration date was reported as 10-JUL-2021 and was confirmed to be valid) (exact dose, route of administration and anatomical location were not reported) for prophylaxis. The haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), was stored in the lowest temperature below 2 Celsius degrees (1.4 Celsius degrees) in time frame 42 minutes. There was no previous temperature excursion. The digital data logger was involved. No adverse effects were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001681: US-009507513-1907USA002782:
Woke up next day with rash. Rash continued to spread for 9days, when I sought care. Was prescribed a topical steroid and antihistimine. Situation is still unresolved.
After the second shot I had the usual fever, chills, headache.  By Wednesday I developed Shingles. It was on my left side inner thigh and genital area.  I saw my OBGYN Dr. .  He confirmed the diagnosis and started me on a prescription for Shingles.
Case number PHEH2013US018287, is an initial spontaneous report from a physician on 27 Aug 2013. This report refers to an 11 years old female patient. She received only Men C, Y, W-135 liquid conjugate component of MENVEO, batch number: not reported), intramuscularly without being reconstituted with Men A lyophilized conjugate vaccine component on 21 Aug 2013, No adverse event was reported following this administration error.
The day after the shot I had a small knot in my arm at the injection site. It was raised, red, hot to the touch , and very sore. By the second day I was fine.  One week later I woke up to a red, hot, itchy knot in my arm at the injection site. Applied  hydrocortisone cream and took a Benedryl. The knot is about the size of a quarter, bigger than the original knot.
Sore throat for a couple of days for two or three days. Developed congestion, pressure in my ears, runny nose, and headache. That lasted another few days. No fevers. I had fatigue. I missed one day of work. I went to urgent care on the 7th. They put me on Augmentin twice a day for a week. I got my flu shot probably mid-September. I had it at Grocery Store. I received it on my left deltoid. I don't know the brand name or lot number.
approximately 15- 20 mins after vaccine given, pt stated mouth feels mild fullness/ swelling, headache, dizziness.  tol water and crackers well, however symptoms did not resolve. 12:25p- MD contacted and pt transferred to the medicine dept for evaluation.
Vomited 10 times, lost 6 pounds, intense chills/body aches, very tired
C/O itching, burning and tightness of throat 10 minutes after flu shot. Given antihistamine, observed for 30 minutes with vital signs monitored- sent to MD.
Vaccine was administered too high on the arm - pain much more intense than average by end of day as compared to years worth of vaccines.   Within 24 hours the shoulder and arm were swollen and pain extended to the arm, neck, shoulder, back, and even towards the waist (right side).  Movement of the shoulder was difficult and very painful.  After 72 hours the pain had diminished and after 96 hours there is still pain but much manageable.
Patient contracted COVID after being fully vaccinated. Fever, headache, runny nose, cough
pull knees to stomach; scream/cry/fretting;vomiting;limp & sleepy; T102-104;enlarged cervical lymph node;severe constipation;hosp;infect disease/surgeon contacted; pockets of pus;Staph infect;16 days of IV antibiotics; hard stools;Annual follow-up received on 10/13/00 states the pt has a scar and immunity problems.
Constantly changing temperature (goes up and down between 98 and 100); Weird issues with my hearing; Flared up temporomandibular joint; Elevated heart rate; Elevated blood pressure (usually at 120. Now it was at 138); Inflamed muscles; Body aches; Weight loss - despite trying to eat a lot more to compensate for it.; Bowel issues; Taste buds altered. I don't taste pineapples and other fruits correctly; Weakness; Fatigue; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the arm left on 04May2021 at 09:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient medical history was not reported. The patient took doxycycline on an unknown date for unknown indication and experienced drug allergy. Concomitant medications included ALLEGRA, montelukast (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm left on 21Apr2021 at 11:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04May2021 at 18:00, the patient experienced constantly changing temperature (goes up and down between 98 and 100), fatigue, weird issues with hearing, flared up temporomandibular joint (TMJ) that has not been present for years, elevated heart rate, elevated blood pressure (usually at 120. It was at 138 at the time of report), these are still going on, 2 weeks after the shot, inflamed muscles, body aches, weakness, weight loss - despite trying to eat a lot more to compensate for it, bowel issues and taste buds altered. The patient don not taste pineapples and other fruits correctly. The adverse events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events constantly changing temperature (goes up and down between 98 and 100), fatigue, weird issues with hearing, flared up temporomandibular joint (TMJ), elevated heart rate, elevated blood pressure (usually at 120. It was at 138 at the time of report), inflamed muscles, body aches, weakness, weight loss, bowel issues and taste buds altered were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning a female who, on an unspecified date was vaccinated intramuscularly with her first dose of GARDASIL (Lot # and site not reported). "About 72 hours post vaccination", the patient developed a rash on her arms and chest. The patient sought unspecified medical attention. No additional information was provided. Additional information has been requested.
Stabbing pain in tonsils for first 72 hours. C/o being lethargic, weak, dizzy, vertigo & joint pain. 3 days after vaccines given had localized bump & wheal show up on left deltoid/subcutaneous tissue. Itchiness, went to urgent care & given topical hydrocortisone on 2/15/13 - did not help. Saw private physician today (2-22-13), given prescription for prednisone & told to come to health department to report symptoms. Has 2 1/2 inch red wheal with 1 inch bump on left arm, 2 1/2 to 3 inches below deltoid toward subcutaneous tissue. TWINRIX & Varicella given on left. Discussed common side effects of vaccines given: TWINRIX (Hep A/Hep B) Lethargy, weakness. MMR (joint aches). Varicella (chicken pox like rash after 2-3 weeks) no vesicles noted. Flu (tenderness at injection site).
From telephone contact with reporter, it was stated that an 18 year old female pt received a Menomune A/C/Y/M-135 vaccination on 7/26/01. On 7/30/01, the pt developed backache and headache. On 8/1/01, the pt developed headache, backache and nausea. On 8/2/01, the pt went to a pediatrician's office; at 14:00, pt was violently throwing up. Pt was admitted to the hospital on 8/3/01 and dx'd with viral meningitis. Pt was released on 8/4/01. From FOLLOW-UP correspondence received on 11/02/2001, it was reported that the patient recovered from this experience. Additional patient vaccine, the correct adverse event onset date and responsible physcian information was also proivided. This case is closed.
had an allergic reaction to it.; This case was reported by a consumer via media and described the occurrence of allergic reaction in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown.   It was unknown if the reporter considered the allergic reaction to be related to Shingles vaccine.  Additional details were provided as follows: Age at vaccination was not reported. The patient received dose of Shingles vaccine and experienced allergic reaction to it. The reporter reported now the pharmacy and his/her primary doctor won't let him/her have second shot.
intermittent numbness on the right side of my lips and tongue; intermittent numbness on the right side of my lips and tongue; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of HYPOAESTHESIA ORAL (intermittent numbness on the right side of my lips and tongue) and the second episode of HYPOAESTHESIA ORAL (intermittent numbness on the right side of my lips and tongue) in a not specif patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced the first episode of HYPOAESTHESIA ORAL (intermittent numbness on the right side of my lips and tongue) and the second episode of HYPOAESTHESIA ORAL (intermittent numbness on the right side of my lips and tongue). At the time of the report, last episode of HYPOAESTHESIA ORAL (intermittent numbness on the right side of my lips and tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. Treatment information was not provided.
Nausea; Diarrhea; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of Nausea; Diarrhea; Dizziness  in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
On 3/5 complained of not feeling well that then turned into vomiting, fever of 101.4, diarrhea, and very tired. Gave 1 Tylenol. Slept for 10+ hours and was back to normal on 3/7 early evening.
Fever, headache, dizziness, stomach pain, slight congestion, redness and pain at injection site - moderate to severe for two days, lessened, but still painful and itchy on day 6.  Muscle twitching in lower lid of left eye for 4 days (so far), and also muscle twitching in left upper thigh.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. In approximately 2015 (reported as since 13-MAR-2015), the patients were vaccinated with doses of GARDASIL lot #K005881, K006960 (expiration dates, dose, route and site of administrations were not reported) that were exposed to temperatures outside of the recommended range. No adverse effects had been observed or reported. Follow up information has been received from the medical assistant on 02-JUL-2015 concerning an adult patient of an unknown age and gender who on 15-JUL-2015 was vaccinated with a dose of GARDASIL (manufacturer unknown) (lot # K006960) (dose and route not reported) that underwent a temperature excursion during 63 hours. This is one of several reports received from the same source. Additional information is not expected as all correspondence was received.
Approximately 10 mins after vaccine, patient reported tongue numbness and dry mouth.  Felt as if tongue was swelling. No dyspnea or chest pain.  Mild anxiety.  Vitals checked and BP was elevated, SaO2 stable as was pulse.  Given 25 mg  Benadryl and improved significantly.  Monitored for additional 20 mins and released to go home.
Headache, muscle ache, nausea got sick 8 hours afterwards of shot.  Still ongoing